Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.
The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.
According to this study, over the next five years the Botulinum Toxins market will register a 13.3% CAGR in terms of revenue, the global market size will reach USD 8500 million by 2024, from USD 4550 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Botulinum Toxins business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Botulinum Toxins market by product type, application, key manufacturers and key regions and countries.
This study considers the Botulinum Toxins value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
50U
100U
Other
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Medical
Cosmetic
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Botulinum Toxins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Botulinum Toxins market by identifying its various subsegments.
Focuses on the key global Botulinum Toxins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Botulinum Toxins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Botulinum Toxins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
